Project Grant HT94252510459
Award Date
9/1/25
Completion Date
8/31/28
Dollars Obligated
$848K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Charlottesville, VA, USA
Similar Awards
The U.S. Department of Defense's Defense Health Agency awarded a $638,260 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Rector & Visitors of the University of Virginia (UVA) with a period of performance from September 1, 2025 to August 31, 2027. The grant supports advanced biomedical research aimed at "Linking Genetic, Metabolic, and Microenvironmental Predictors of Melanoma Metastatic Colonization." As a prominent academic...
The University of Virginia was awarded a $2,728,777 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on May 1, 2025, will support advanced biomedical research on "Neuroactive Steroid Biosynthesis and Dynamic GABAA Receptor Reconfiguration in Postpartum Depression" over a performance period ending on April 30, 2029. This research aims to transform healthcare for military service...
This federal Project Grant award of $1,592,860.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The award was granted to the Rector & Visitors of the University of Virginia, a prominent academic research institution, to conduct ultrasensitive proteomics research for type 1 diabetes prediction and treatment efficacy...
The U.S. Defense Health Agency (DHA) awarded a $5,540,949 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Rector & Visitors of the University of Virginia (UVA) to conduct focused ultrasound interventions research for the noninvasive treatment of primary and metastatic breast cancers. The 4-year grant, awarded on September 30, 2025, supports UVA's work to develop advanced focused ultrasound technologies for precise, non-surgical cancer therapies....
The University of Virginia will receive $748,422 under a three-year Project Grant award from the Department of the Army Medical Command. The award is funded through the Military Medical Research and Development program (CFDA 12.420). The University will quantify the relationship between brain biomechanics and head exposures relevant to warfighters. Insights gained from this research aim to guide the development of future injury prevention technologies. Specifically, the University seeks to...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $3,208,546.00 to the Rector & Visitors of the University of Virginia (UVA) to expand the Generalized Blast Exposure Value Tool. The goal is to determine cumulative blast exposure thresholds in military populations. The award period runs from May 15, 2025 to May 14, 2029. UVA, a prominent academic research institution, will leverage its expertise across...
The University of Virginia (UVA) received a $888,251 Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research comparing the effectiveness of a hybrid versus lecture-based training approach for improving first responder competence in autism response. The project, titled "AUTISM RESPONSE PROTOCOL: COMPARING THE EFFECTIVENESS OF A HYBRID VS LECTURE-BASED TRAINING ON AUTISM COMPETENCE IN FIRST RESPONDERS", will...
The University of Virginia received a $921,351 project grant award on September 30, 2023 from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to support research on "APPROACHES TO ENHANCE VACCINE-INDUCED TUMOR-INFILTRATING LYMPHOCYTES (VITILS) IN MELANOMA". This multi-year grant, scheduled for completion on September 29, 2026, aims to advance biomedical research that can transform healthcare for Service Members and the American public. The...
This $693,642 federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports research at the University of Virginia to enhance vaccine-induced tumor-infiltrating lymphocytes (VITILS) in melanoma. The 3-year research project aims to develop innovative approaches to boost the effectiveness of cancer immunotherapies by improving the ability of T cells to infiltrate and attack melanoma tumors. Key deliverables will include...
The University of Virginia will receive $238,794 from the Defense Health Agency under a Project Grant award to investigate the mechanisms of seizure-induced death in TSC model mice. The research, to be conducted from June 2023 through May 2025 in Charlottesville, Virginia, aims to further the Military Medical Research and Development program's goal of transforming military and public health through innovative biomedical research solutions. Specifically, the grant will fund the university's...